Description
Pi™, Prostate Intelligence™, is an AI and machine learning based software system designed to help radiologists detect and report the presence of prostate cancer lesions from MR scans (MRI).
We designed Pi to augment a radiologist’s interpretation of prostate MRI in three ways:
- Improve patient selection/prioritisation for biopsy
This is achieved by outputting a risk score aiming for both high negative predictive value (NPV) and specificity. Depending on clinical priorities, this could be used to reduce unnecessary biopsies and overdiagnosis of insignificant cancers, streamline workflow or waiting lists, or help reduce radiologists workload
- Improve identification of targets for biopsy
This involves identifying candidate regions of interest with high NPV, to help ensure that all areas of suspicion are targeted for biopsy and help reduce underdiagnosis (missed clinically significant cancers)
- Provide high quality segmentations
Outputting machine generated segmentations that compare well to human expert annotations, to support visualisation, analysis and biopsy targeting
Please note that Pi does not make a direct diagnosis and is only available in selected countries. Contact Lucida Medical for further details. The software is not for sale in the US.